Selected research
Market Structure
Global Iodinated X-Ray Contrast Media Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Iodinated X-Ray Contrast Media market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Iodinated X-Ray Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Iodinated X-Ray Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Iodinated X-Ray Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Iodinated X-Ray Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Iodinated X-Ray Contrast Media include Bayer, Bracco, Cadiasun Pharma GmbH, Daiichi Sankyo, Fuji Pharma, GE Healthcare, Grupo Juste, Guerbet and Imax, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Iodinated X-Ray Contrast Media market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Iodinated X-Ray Contrast Media and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Iodinated X-Ray Contrast Media sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iodinated X-Ray Contrast Media market size, projected growth trends, production technologies, key applications, and end-use industries.
Iodinated X-Ray Contrast Media Segment by Company
Bayer
Bracco
Cadiasun Pharma GmbH
Daiichi Sankyo
Fuji Pharma
GE Healthcare
Grupo Juste
Guerbet
Imax
Liebel-Flarsheim Company LLC
Neptunus Bio-pharmaceutical
Takeda
BeiLu Pharma
Brilliant Pharmaceutical
Hengrui Pharmaceuticals
Consun Pharmaceutical
Shenghuaxi Pharmaceutical
YRPG
CTTQ
Iodinated X-Ray Contrast Media Segment by Type
Iodixanol
Iohexol
Ioversol
Iobitrol
Others
Iodinated X-Ray Contrast Media Segment by Application
Hospital
Clinic
Others
Iodinated X-Ray Contrast Media Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iodinated X-Ray Contrast Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Iodinated X-Ray Contrast Media and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iodinated X-Ray Contrast Media.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Iodinated X-Ray Contrast Media market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Iodinated X-Ray Contrast Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Iodinated X-Ray Contrast Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Iodinated X-Ray Contrast Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Iodixanol
- Iohexol
- Ioversol
- Iobitrol
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Bayer
- Bracco
- Cadiasun Pharma GmbH
- Daiichi Sankyo
- Fuji Pharma
- GE Healthcare
- Grupo Juste
- Guerbet
- Imax
- Liebel-Flarsheim Company LLC
- Neptunus Bio-pharmaceutical
- Takeda
- BeiLu Pharma
- Brilliant Pharmaceutical
- Hengrui Pharmaceuticals
- Consun Pharmaceutical
- Shenghuaxi Pharmaceutical
- YRPG
- CTTQ
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Iodinated X-Ray Contrast Media Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Iodinated X-Ray Contrast Media Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Iodinated X-Ray Contrast Media Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Iodinated X-Ray Contrast Media Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Iodinated X-Ray Contrast Media Market Dynamics
- 2.1 Iodinated X-Ray Contrast Media Industry Trends
- 2.2 Iodinated X-Ray Contrast Media Industry Drivers
- 2.3 Iodinated X-Ray Contrast Media Industry Opportunities and Challenges
- 2.4 Iodinated X-Ray Contrast Media Industry Restraints
3 Iodinated X-Ray Contrast Media Market by Manufacturers
- 3.1 Global Iodinated X-Ray Contrast Media Revenue by Manufacturers (2021-2026)
- 3.2 Global Iodinated X-Ray Contrast Media Sales by Manufacturers (2021-2026)
- 3.3 Global Iodinated X-Ray Contrast Media Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Iodinated X-Ray Contrast Media Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Iodinated X-Ray Contrast Media Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Iodinated X-Ray Contrast Media Manufacturers, Product Type & Application
- 3.7 Global Iodinated X-Ray Contrast Media Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Iodinated X-Ray Contrast Media Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Iodinated X-Ray Contrast Media Players Market Share by Revenue in 2025
- 3.8.3 2025 Iodinated X-Ray Contrast Media Tier 1, Tier 2, and Tier 3
4 Iodinated X-Ray Contrast Media Market by Type
- 4.1 Iodinated X-Ray Contrast Media Type Introduction
- 4.1.1 Iodixanol
- 4.1.2 Iohexol
- 4.1.3 Ioversol
- 4.1.4 Iobitrol
- 4.1.5 Others
- 4.2 Global Iodinated X-Ray Contrast Media Sales by Type
- 4.2.1 Global Iodinated X-Ray Contrast Media Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Iodinated X-Ray Contrast Media Sales by Type (2021-2032)
- 4.2.3 Global Iodinated X-Ray Contrast Media Sales Market Share by Type (2021-2032)
- 4.3 Global Iodinated X-Ray Contrast Media Revenue by Type
- 4.3.1 Global Iodinated X-Ray Contrast Media Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Iodinated X-Ray Contrast Media Revenue by Type (2021-2032)
- 4.3.3 Global Iodinated X-Ray Contrast Media Revenue Market Share by Type (2021-2032)
5 Iodinated X-Ray Contrast Media Market by Application
- 5.1 Iodinated X-Ray Contrast Media Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Iodinated X-Ray Contrast Media Sales by Application
- 5.2.1 Global Iodinated X-Ray Contrast Media Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Iodinated X-Ray Contrast Media Sales by Application (2021-2032)
- 5.2.3 Global Iodinated X-Ray Contrast Media Sales Market Share by Application (2021-2032)
- 5.3 Global Iodinated X-Ray Contrast Media Revenue by Application
- 5.3.1 Global Iodinated X-Ray Contrast Media Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Iodinated X-Ray Contrast Media Revenue by Application (2021-2032)
- 5.3.3 Global Iodinated X-Ray Contrast Media Revenue Market Share by Application (2021-2032)
6 Global Iodinated X-Ray Contrast Media Sales by Region
- 6.1 Global Iodinated X-Ray Contrast Media Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Iodinated X-Ray Contrast Media Sales by Region (2021-2032)
- 6.2.1 Global Iodinated X-Ray Contrast Media Sales by Region (2021-2026)
- 6.2.2 Global Iodinated X-Ray Contrast Media Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Iodinated X-Ray Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Iodinated X-Ray Contrast Media Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Iodinated X-Ray Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Iodinated X-Ray Contrast Media Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Iodinated X-Ray Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Iodinated X-Ray Contrast Media Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Iodinated X-Ray Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Iodinated X-Ray Contrast Media Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Iodinated X-Ray Contrast Media Revenue by Region
- 7.1 Global Iodinated X-Ray Contrast Media Revenue by Region
- 7.1.1 Global Iodinated X-Ray Contrast Media Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Iodinated X-Ray Contrast Media Revenue by Region (2021-2026)
- 7.1.3 Global Iodinated X-Ray Contrast Media Revenue by Region (2027-2032)
- 7.1.4 Global Iodinated X-Ray Contrast Media Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Iodinated X-Ray Contrast Media Revenue (2021-2032)
- 7.2.2 North America Iodinated X-Ray Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Iodinated X-Ray Contrast Media Revenue (2021-2032)
- 7.3.2 Europe Iodinated X-Ray Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Iodinated X-Ray Contrast Media Revenue (2021-2032)
- 7.4.2 Asia-Pacific Iodinated X-Ray Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Iodinated X-Ray Contrast Media Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Iodinated X-Ray Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Bayer
- 8.1.1 Bayer Company Information
- 8.1.2 Bayer Business Overview
- 8.1.3 Bayer Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Bayer Iodinated X-Ray Contrast Media Product Portfolio
- 8.1.5 Bayer Recent Developments
- 8.2 Bracco
- 8.2.1 Bracco Company Information
- 8.2.2 Bracco Business Overview
- 8.2.3 Bracco Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Bracco Iodinated X-Ray Contrast Media Product Portfolio
- 8.2.5 Bracco Recent Developments
- 8.3 Cadiasun Pharma GmbH
- 8.3.1 Cadiasun Pharma GmbH Company Information
- 8.3.2 Cadiasun Pharma GmbH Business Overview
- 8.3.3 Cadiasun Pharma GmbH Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Cadiasun Pharma GmbH Iodinated X-Ray Contrast Media Product Portfolio
- 8.3.5 Cadiasun Pharma GmbH Recent Developments
- 8.4 Daiichi Sankyo
- 8.4.1 Daiichi Sankyo Company Information
- 8.4.2 Daiichi Sankyo Business Overview
- 8.4.3 Daiichi Sankyo Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Daiichi Sankyo Iodinated X-Ray Contrast Media Product Portfolio
- 8.4.5 Daiichi Sankyo Recent Developments
- 8.5 Fuji Pharma
- 8.5.1 Fuji Pharma Company Information
- 8.5.2 Fuji Pharma Business Overview
- 8.5.3 Fuji Pharma Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Fuji Pharma Iodinated X-Ray Contrast Media Product Portfolio
- 8.5.5 Fuji Pharma Recent Developments
- 8.6 GE Healthcare
- 8.6.1 GE Healthcare Company Information
- 8.6.2 GE Healthcare Business Overview
- 8.6.3 GE Healthcare Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 GE Healthcare Iodinated X-Ray Contrast Media Product Portfolio
- 8.6.5 GE Healthcare Recent Developments
- 8.7 Grupo Juste
- 8.7.1 Grupo Juste Company Information
- 8.7.2 Grupo Juste Business Overview
- 8.7.3 Grupo Juste Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Grupo Juste Iodinated X-Ray Contrast Media Product Portfolio
- 8.7.5 Grupo Juste Recent Developments
- 8.8 Guerbet
- 8.8.1 Guerbet Company Information
- 8.8.2 Guerbet Business Overview
- 8.8.3 Guerbet Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Guerbet Iodinated X-Ray Contrast Media Product Portfolio
- 8.8.5 Guerbet Recent Developments
- 8.9 Imax
- 8.9.1 Imax Company Information
- 8.9.2 Imax Business Overview
- 8.9.3 Imax Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Imax Iodinated X-Ray Contrast Media Product Portfolio
- 8.9.5 Imax Recent Developments
- 8.10 Liebel-Flarsheim Company LLC
- 8.10.1 Liebel-Flarsheim Company LLC Company Information
- 8.10.2 Liebel-Flarsheim Company LLC Business Overview
- 8.10.3 Liebel-Flarsheim Company LLC Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Liebel-Flarsheim Company LLC Iodinated X-Ray Contrast Media Product Portfolio
- 8.10.5 Liebel-Flarsheim Company LLC Recent Developments
- 8.11 Neptunus Bio-pharmaceutical
- 8.11.1 Neptunus Bio-pharmaceutical Company Information
- 8.11.2 Neptunus Bio-pharmaceutical Business Overview
- 8.11.3 Neptunus Bio-pharmaceutical Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Neptunus Bio-pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio
- 8.11.5 Neptunus Bio-pharmaceutical Recent Developments
- 8.12 Takeda
- 8.12.1 Takeda Company Information
- 8.12.2 Takeda Business Overview
- 8.12.3 Takeda Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Takeda Iodinated X-Ray Contrast Media Product Portfolio
- 8.12.5 Takeda Recent Developments
- 8.13 BeiLu Pharma
- 8.13.1 BeiLu Pharma Company Information
- 8.13.2 BeiLu Pharma Business Overview
- 8.13.3 BeiLu Pharma Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 BeiLu Pharma Iodinated X-Ray Contrast Media Product Portfolio
- 8.13.5 BeiLu Pharma Recent Developments
- 8.14 Brilliant Pharmaceutical
- 8.14.1 Brilliant Pharmaceutical Company Information
- 8.14.2 Brilliant Pharmaceutical Business Overview
- 8.14.3 Brilliant Pharmaceutical Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Brilliant Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio
- 8.14.5 Brilliant Pharmaceutical Recent Developments
- 8.15 Hengrui Pharmaceuticals
- 8.15.1 Hengrui Pharmaceuticals Company Information
- 8.15.2 Hengrui Pharmaceuticals Business Overview
- 8.15.3 Hengrui Pharmaceuticals Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Hengrui Pharmaceuticals Iodinated X-Ray Contrast Media Product Portfolio
- 8.15.5 Hengrui Pharmaceuticals Recent Developments
- 8.16 Consun Pharmaceutical
- 8.16.1 Consun Pharmaceutical Company Information
- 8.16.2 Consun Pharmaceutical Business Overview
- 8.16.3 Consun Pharmaceutical Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Consun Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio
- 8.16.5 Consun Pharmaceutical Recent Developments
- 8.17 Shenghuaxi Pharmaceutical
- 8.17.1 Shenghuaxi Pharmaceutical Company Information
- 8.17.2 Shenghuaxi Pharmaceutical Business Overview
- 8.17.3 Shenghuaxi Pharmaceutical Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Shenghuaxi Pharmaceutical Iodinated X-Ray Contrast Media Product Portfolio
- 8.17.5 Shenghuaxi Pharmaceutical Recent Developments
- 8.18 YRPG
- 8.18.1 YRPG Company Information
- 8.18.2 YRPG Business Overview
- 8.18.3 YRPG Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 YRPG Iodinated X-Ray Contrast Media Product Portfolio
- 8.18.5 YRPG Recent Developments
- 8.19 CTTQ
- 8.19.1 CTTQ Company Information
- 8.19.2 CTTQ Business Overview
- 8.19.3 CTTQ Iodinated X-Ray Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 CTTQ Iodinated X-Ray Contrast Media Product Portfolio
- 8.19.5 CTTQ Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Iodinated X-Ray Contrast Media Value Chain Analysis
- 9.1.1 Iodinated X-Ray Contrast Media Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Iodinated X-Ray Contrast Media Production Mode & Process
- 9.2 Iodinated X-Ray Contrast Media Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Iodinated X-Ray Contrast Media Distributors
- 9.2.3 Iodinated X-Ray Contrast Media Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst